Display options
Share it on

J Gerontol A Biol Sci Med Sci. 2021 Aug 13;76(9):1692-1698. doi: 10.1093/gerona/glab143.

Impact of Cardiovascular Risk Factors in Adolescence, Young Adulthood, and Midlife on Late-Life Cognition: Study of Healthy Aging in African Americans.

The journals of gerontology. Series A, Biological sciences and medical sciences

Kristen M George, Paola Gilsanz, Rachel L Peterson, Lisa L Barnes, Charles S DeCarli, Elizabeth Rose Mayeda, Dan M Mungas, Rachel A Whitmer

Affiliations

  1. Department of Neurology, University of California Davis School of Medicine, Sacramento, USA.
  2. Kaiser Permanente Division of Research, Oakland, California, USA.
  3. Rush Alzheimer's Disease Center, Rush Medical College, Chicago, Illinois, USA.
  4. Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, USA.
  5. Department of Public Health Sciences, University of California Davis School of Medicine, Sacramento, USA.

PMID: 34387334 PMCID: PMC8361347 DOI: 10.1093/gerona/glab143

Abstract

BACKGROUND: Midlife cardiovascular risk factors (CVRFs) increase risk of dementia. Black Americans experience an elevated prevalence of CVRFs and dementia. However, little is known of how CVRFs prior to midlife affect late-life cognition. We examined CVRFs in adolescence, young adulthood, and midlife with late-life cognition in the Study of Healthy Aging in African Americans (STAR).

METHOD: STAR assesses cognitive aging among 764 Black Americans aged ≥50 (mean age = 69; SD = 9; range = 53-95). Participants' body mass index, blood pressure, glucose, and total cholesterol were collected during Multiphasic Health Checkups (MHC; 1964-1985). At STAR baseline (2018-2019), executive function, verbal episodic memory, and semantic memory were measured using the Spanish and English Neuropsychological Assessment Scales. Linear regression models examined associations between CVRFs and cognition adjusting for demographics and years since MHC.

RESULTS: At MHC, 36% of participants had 1 CVRF and 26% had ≥2. Twenty-two percent of participants were adolescents (age 12-20), 62% young adults (age 21-34), and 16% midlife adults (age 35-56). Overweight/obesity was not associated with cognition. Hypertension was associated with worse executive function (β [95% CI]: -0.14 [-0.28, -0.0003]) and verbal episodic memory (β [95% CI]: -0.22 [-0.37, -0.07]) compared to normotension. Diabetes was associated with worse executive function (β [95% CI]: -0.43 [-0.83, -0.03]). Having ≥2 CVRFs (vs 0) was associated with worse executive function (β [95% CI]: -0.19 [-0.34, -0.03]) and verbal episodic memory (β [95% CI]: -0.25 [-0.41, -0.08]). Adolescents with hypertension had lower late-life executive function compared to normotensive adolescents (β [95% CI]: -0.39 [-0.67, -0.11]). Young adulthood hypertension (β [95% CI]: -0.29 [-0.49, -0.09]) and midlife hyperlipidemia (β [95% CI]: -0.386 [-0.70, -0.02]) were associated with lower verbal episodic memory.

CONCLUSIONS: Among Black Americans, life-course CVRFs were associated with poorer executive function and verbal episodic memory emphasizing the importance of cardiovascular health on the aging brain.

© The Author(s) 2021. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: [email protected].

Keywords: Black Americans; Cardiovascular disease; Cognitive aging; Dementia; Life course

References

  1. Psychol Aging. 2009 Mar;24(1):116-28 - PubMed
  2. Am J Geriatr Psychiatry. 2008 May;16(5):343-54 - PubMed
  3. Diabetes Care. 2016 May;39(5):668-76 - PubMed
  4. Am J Public Health. 2006 May;96(5):826-33 - PubMed
  5. Diabetes Care. 2014 Apr;37(4):1009-15 - PubMed
  6. Alzheimers Dement. 2019 Feb;15(2):292-312 - PubMed
  7. Ann Intern Med. 2002 Aug 6;137(3):149-55 - PubMed
  8. Neurology. 2017 Oct 31;89(18):1886-1893 - PubMed
  9. Alzheimers Dement. 2019 Jul;15(7):888-898 - PubMed
  10. J Am Heart Assoc. 2017 Jun 21;6(6): - PubMed
  11. J Int Neuropsychol Soc. 2005 Sep;11(5):620-30 - PubMed
  12. J Alzheimers Dis. 2019;68(1):145-158 - PubMed
  13. Neuropsychology. 2018 Jan;32(1):77-88 - PubMed
  14. Neuropsychology. 2018 May;32(4):436-449 - PubMed
  15. Ethn Dis. 2019 Jan 17;29(1):47-52 - PubMed
  16. J Alzheimers Dis. 2012;32(3):531-40 - PubMed
  17. Dement Geriatr Cogn Disord. 2009;28(1):75-80 - PubMed
  18. Neurology. 2005 Jan 25;64(2):277-81 - PubMed
  19. Alzheimers Dement. 2014 Sep;10(5):562-70 - PubMed
  20. J Int Neuropsychol Soc. 2021 May;27(5):401-411 - PubMed
  21. Curr Hypertens Rep. 2017 Mar;19(3):24 - PubMed
  22. Alzheimers Dement. 2018 Nov;14(11):1406-1415 - PubMed
  23. Arch Neurol. 2005 Oct;62(10):1556-60 - PubMed
  24. Neuropsychology. 2005 Jul;19(4):466-75 - PubMed
  25. Stroke. 2021 Jun;52(6):e295-e308 - PubMed
  26. Curr Alzheimer Res. 2012 Jul;9(6):734-45 - PubMed
  27. Psychol Aging. 2010 Sep;25(3):606-19 - PubMed
  28. Neuropsychology. 2018 Jul;32(5):529-540 - PubMed
  29. Neuropsychology. 2014 Nov;28(6):846-58 - PubMed
  30. Am J Prev Med. 2016 Oct;51(4):502-6 - PubMed
  31. Neurobiol Aging. 2019 Nov;83:95-104 - PubMed
  32. Alzheimers Dement. 2016 Mar;12(3):216-24 - PubMed
  33. Age Ageing. 2016 Jan;45(1):14-21 - PubMed
  34. Neuropsychology. 2000 Apr;14(2):209-23 - PubMed
  35. Psychol Aging. 2013 Sep;28(3):633-45 - PubMed
  36. Diabetes Care. 2019 Jul;42(7):1248-1254 - PubMed
  37. J Gerontol B Psychol Sci Soc Sci. 2015 Jul;70(4):519-31 - PubMed
  38. Neurology. 2020 Aug 18;95(7):e839-e846 - PubMed
  39. Nat Rev Endocrinol. 2018 Oct;14(10):591-604 - PubMed
  40. J Int Neuropsychol Soc. 2008 Sep;14(5):746-59 - PubMed
  41. Am J Public Health. 2005 Aug;95(8):1417-23 - PubMed
  42. PLoS One. 2016 Aug 23;11(8):e0161770 - PubMed
  43. J Physiol. 2016 Apr 15;594(8):2061-73 - PubMed
  44. Alzheimers Dement. 2016 Mar;12(3):292-323 - PubMed
  45. Epidemiology. 2018 Jan;29(1):151-159 - PubMed
  46. JAMA. 1995 Dec 20;274(23):1846-51 - PubMed
  47. Neuropsychology. 2011 Mar;25(2):260-269 - PubMed
  48. Neuroimage. 2011 Jan 15;54(2):1530-9 - PubMed
  49. Psychol Assess. 2004 Dec;16(4):347-59 - PubMed
  50. Neurology. 2017 Dec 5;89(23):2381-2391 - PubMed
  51. Neurobiol Aging. 2018 Aug;68:142-150 - PubMed
  52. J Pediatr. 2009 Sep;155(3):S7.e7-11 - PubMed
  53. J Am Geriatr Soc. 2016 May;64(5):959-64 - PubMed
  54. Alzheimers Dement. 2017 Apr;13(4):454-467 - PubMed
  55. Brain. 2010 Aug;133(Pt 8):2196-209 - PubMed
  56. Health Psychol. 2016 Apr;35(4):407-11 - PubMed
  57. Nutr Metab Cardiovasc Dis. 2012 Feb;22(2):141-8 - PubMed
  58. Neurology. 2018 Oct 16;91(16):e1479-e1486 - PubMed
  59. J Am Heart Assoc. 2017 Sep 22;6(9): - PubMed
  60. J Neurol Sci. 2009 May 15;280(1-2):79-83 - PubMed
  61. Curr Alzheimer Res. 2007 Apr;4(2):103-9 - PubMed
  62. BMJ. 2005 Jun 11;330(7504):1360 - PubMed
  63. Neuropsychologia. 2008 Jan 15;46(1):12-21 - PubMed
  64. Diabetes Care. 2015 Jun;38(6):1082-8 - PubMed
  65. Obes Rev. 2011 May;12(5):e426-37 - PubMed
  66. Ann Clin Transl Neurol. 2019 Dec;6(12):2403-2412 - PubMed
  67. J Int Neuropsychol Soc. 2006 Sep;12(5):707-35 - PubMed
  68. Neurology. 2015 Aug 11;85(6):528-34 - PubMed
  69. JAMA. 2019 Feb 12;321(6):553-561 - PubMed

Publication Types

Grant support